United States Veterinary Stereotactic Radiosurgery System Market to Grow with a CAGR of 9.44% through 2030
Increased
veterinary healthcare expenditure and technological advancements in
radiosurgery systems, is expected to drive the United States Veterinary
Stereotactic Radiosurgery System Market growth in the forecast period, 2026-2030
According to
TechSci Research report, “United States Veterinary Stereotactic Radiosurgery
System Market – By Region and Competition, Forecast & Opportunities, 2030F”,
the United States Veterinary Stereotactic Radiosurgery System Market was valued
at USD 1.18 Billion in
2024 and is expected to reach USD 2.03 Billion by 2030 with a CAGR of 9.44%. The
United States Veterinary Stereotactic Radiosurgery System Market is evolving
with the growing shift in veterinary care from conventional treatment methods
to technologically advanced therapeutic solutions. Rising pet longevity and
improvements in diagnostic imaging are allowing early detection of complex
diseases, particularly tumors affecting critical organs. Pet owners are showing
greater interest in minimally invasive treatment options that ensure shorter
recovery times and higher success rates. This changing perception of companion
animal healthcare is prompting veterinary clinics to invest in next-generation
treatment modalities like stereotactic radiosurgery systems, which can deliver
focused therapy with minimal side effects.
The
market is also influenced by the expanding ecosystem of veterinary oncology.
Specialized veterinary centers are increasingly incorporating
multi-disciplinary treatment protocols involving surgery, chemotherapy, and
radiosurgery. The growing availability of modular radiosurgery platforms, which
can be tailored to specific treatment needs, is helping more clinics adopt this
technology. Industry players are enhancing device usability by integrating
compact, high-efficiency components and user-friendly software interfaces. The
increased involvement of veterinary schools in research and clinical
application of radiosurgery is encouraging wider dissemination of knowledge and
more effective treatment adoption across practices of varying sizes.
There
are substantial growth opportunities emerging as awareness of advanced animal
oncology care spreads beyond urban settings. The demand for pet cancer
treatment is creating a fertile ground for mobile and tele-radiotherapy
services, expanding reach into underserved regions. Collaborations between
private veterinary groups and technology manufacturers can accelerate equipment
deployment in community clinics. Financial innovations such as equipment
leasing or revenue-sharing models may lower the barriers for smaller practices
to offer high-end radiosurgery treatments. As the market continues to develop,
education and certification programs for veterinary professionals in
radiosurgical techniques will play a pivotal role in expanding access and
ensuring consistent treatment quality across the country.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "United States Veterinary Stereotactic Radiosurgery System Market”
The United
States Veterinary Stereotactic Radiosurgery System Market is segmented into product,
application, end user, regional distribution, and company.
Based on the Application,
Brain Tumours emerged as the fastest growing segment in the United States
Veterinary Stereotactic Radiosurgery System Market during the forecast period. This
can be attributed to the increasing prevalence of brain tumors in pets,
particularly in dogs and cats. Brain tumors are often difficult to treat
through conventional surgical methods due to the sensitive location and the
potential risks associated with invasive procedures. As a result, SRS has
become a preferred non-invasive treatment option for these tumors, offering
precise targeting of the tumor while minimizing damage to surrounding healthy
tissue. The growing awareness among pet owners about advanced treatments for
brain tumors and the rising demand for specialized veterinary care have
contributed to the rapid adoption of SRS for brain tumor treatment.
Based
on the Region, West emerged as the fastest growing region in the United
States Veterinary Stereotactic Radiosurgery System Market during the forecast period. This is driven
by a strong concentration of advanced veterinary care infrastructure, a high
volume of companion animal ownership, and progressive adoption of innovative
medical technologies. States such as California, Washington, and Colorado are
home to a dense network of specialty veterinary hospitals and research-focused
veterinary institutions that are early adopters of cutting-edge oncology
equipment, including stereotactic radiosurgery systems. These facilities are
increasingly investing in high-precision treatment tools to address complex
neurological and oncological conditions in pets. The region's robust pet care
culture, characterized by greater willingness among pet owners to pursue
advanced and specialized treatments, fuels demand for minimally invasive cancer
therapies. In addition, the presence of several veterinary schools, cancer
research centers, and medical device companies fosters a favorable ecosystem
for technological advancement and clinical application.
Major
companies operating in United States Veterinary Stereotactic Radiosurgery
System Market are:
- Avante
Health Solutions
- Accuray
Inc.
- Elekta
AB
- Varian
Medical Systems Inc.
- PetCure
Oncology
- Xstrahl
Inc.
- CVS
Group
- Medtronic
PLC
- Nanovi
AS
- Merck
& Co. Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The United States Veterinary
Stereotactic Radiosurgery System Market is expanding due to the increasing
adoption of advanced cancer treatment technologies in veterinary clinics, with
a particular focus on improving precision and reducing side effects for pets.
The growing awareness among pet owners regarding the availability of
non-invasive, highly effective treatment options for cancer, such as
stereotactic radiosurgery, is driving this trend. As more veterinary
institutions invest in cutting-edge technologies like linear accelerators and
robotic platforms, the market is poised for significant growth. This shift
towards technologically advanced solutions aligns with the broader trend of
enhancing veterinary care with state-of-the-art equipment. These developments
are boosting the demand for specialized stereotactic radiosurgery systems that
offer high levels of accuracy and minimal discomfort for animals, ensuring
better outcomes.,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“United States Veterinary
Stereotactic Radiosurgery System Market By Product (Gamma Knife, LINAC, Proton
Beam Radiation Therapy (PBRT)/ Flash-RT, CyberKnife), By Application (Brain
Tumours, Spinal Tumours, Other Applications), By End User (Veterinary Hospitals,
Veterinary Specialty Clinics, Research and Academic Institutions), By Region, Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of United States Veterinary
Stereotactic Radiosurgery System Market and provides statistics &
information on market size, structure and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in United States Veterinary Stereotactic Radiosurgery System
Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com